Will Donors Return After Deferral: One Center’s Experience with Reinstatement After New FDA Guidance on Creutzfeldt-Jakob Disease
Our Experience in Using A1 Lectin for Solid Organ Transplant Triaging Between Group A1 and Non-Group A1 Donors
Implementing an Integrated Communication System Between an Apheresis Device and Our Center’s Blood Establishment Computer System
Analysis of the Benefit of Implementing a Helipad for Rotation and Resupply of Low Titer O Whole Blood to Prehospital Entities
